PT-141 (Bremelanotide)

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist derived from Melanotan II and studied for its interaction with central melanocortin signaling pathways. It selectively targets melanocortin receptors involved in neuroendocrine and behavioral regulation. Preclinical research utilizes PT-141 to investigate receptor binding dynamics, cAMP-mediated signaling activity, and melanocortin pathway modulation under controlled laboratory conditions.

For research use only. Not for human consumption.